EUVIMEDEUVIMED entdecken
Crossref

Analysis of the Cost-Effectiveness of Treatment Strategies for Acute-on-Chronic Liver Failure

Wei-Bo Guo, Xi-Ju Guo, Meng-Yao Zheng, Xuan-Cheng Xie, Yong-Pin Wang, Bo Gan, Jin-Hui Yang

Transplantation Proceedings · 2025

DOI: 10.1016/j.transproceed.2025.08.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplantation Proceedings, 2025. Verfasst von Wei-Bo Guo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Acute-On-Chronic Liver Failure, Liver, Artificial, Plasma Exchange. Die Arbeit nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study aimed to evaluate the cost-effectiveness of 3 artificial liver models, plasma exchange (PE), the double plasma molecular absorption system (DPMAS), and a combination of plasma exchange with the double plasma molecular absorption system (PE + DPMAS) as well as medical drugs in treating patients with acute-on-chronic liver failure. METHODS: A retrospective approach was employed to collect clinical data from electronic medical records. The study included 296 patients who met the inclusion criteria and were categorized based on their treatment into 2 groups: the medical treatment group and the artificial liver group, the latter of which included PE, DPMAS, and PE + DPMAS. To compare the costs and effectiveness of the medical treatment group with the 3 artificial liver treatment groups, a pharmacoeconomic cost-effectiveness analysis was conducted to assess the economic aspects. RESULTS: The effectiveness rate of the PE + DPMAS group was 76.9%, which was significantly higher than that of the PE and DPMAS group (P .05). The effectiveness rate in all 3 artificial liver treatment groups was higher than that of the medical treatment group (P < .05). The total cost per person was RMB 54,661.6, RMB 61,385.5, RMB 71,789.2, and RMB 65,945.7 in the medical treatment, and the artificial liver PE group, DPMAS, and PE + DPMAS groups, respectively. The cost-effectiveness ratio (C/E) was 2009.6, 1162.6, 1511.4, and 758.9, respectively. The sensitivity analysis results for costs were consistent with the cost-effectiveness analysis results. CONCLUSIONS: The artificial liver treatment group demonstrated a superior "performance-cost ratio," with the PE + DPMAS group being the most effective. This combination can be considered the optimal treatment for acute-on-chronic liver failure when combined with appropriate drug therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute-On-Chronic Liver FailureLiver, ArtificialPlasma ExchangeHumansCost-Benefit AnalysisRetrospective StudiesMaleFemaleMiddle AgedAdultDrug CostsTreatment Outcome

Autor:innen und Institutionen

  • Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Department of Gastroenterology, Baoshan People's Hospital, Baoshan, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Electronic address: jinhuiyangyjhd@126.com.

Zitieren

APA

Guo, W. B., Guo, X. J., Zheng, M. Y., Xie, X. C., Wang, Y. P., Gan, B., & Yang, J. H. (2025). Analysis of the Cost-Effectiveness of Treatment Strategies for Acute-on-Chronic Liver Failure. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2025.08.026

Vancouver

Guo WB, Guo XJ, Zheng MY, Xie XC, Wang YP, Gan B, et al. Analysis of the Cost-Effectiveness of Treatment Strategies for Acute-on-Chronic Liver Failure. Transplantation Proceedings. 2025. doi:10.1016/j.transproceed.2025.08.026

BibTeX
@article{Guo2025,
  author = {Guo, Wei-Bo and Guo, Xi-Ju and Zheng, Meng-Yao and Xie, Xuan-Cheng and Wang, Yong-Pin and Gan, Bo and Yang, Jin-Hui},
  title = {Analysis of the Cost-Effectiveness of Treatment Strategies for Acute-on-Chronic Liver Failure},
  journal = {Transplantation Proceedings},
  year = {2025},
  doi = {10.1016/j.transproceed.2025.08.026}
}
Kostenlos starten →